脱乙硫酸 (DHEAS) 是一种内源性Kv7通道调节器,可降低Kv7/M电流抑制和炎症性疼痛
Lamees Alhassen1, Wedad Alhassen1, Cindy Wong1
1Department of Pharmaceutical Sciences, University of California-Irvine, Irvine, California 92697.
概括
脱乙硫酸 (DHEAS) 是神经元Kv7通道的新型调节器,可以减弱M电流抑制. 这种内源性类固醇激素在体内减轻炎症性疼痛,表明神经系统疾病的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 神经元Kv7电压通道,负责M电流,是神经元刺激的关键调节者.
- 通过Gq合受体抑制M电流会增加神经元刺激能力,这种机制与各种神经疾病有关.
研究的目的:
- 为了确定Kv7通道的内源调节剂.
- 调查脱乙硫酸 (DHEAS) 在调节M电流和神经元刺激性方面的作用.
- 探索DHEAS作为治疗炎症性疼痛的治疗剂的潜力.
主要方法:
- 在原生神经元和异质表达系统中对Kv7电流的电生理学记录.
- 生物化学测试以评估受体合信号通路.
- 计算机建模用于预测DHEAS结合点.
- 位点定向突变发生,以验证结合位点预测.
- 在动物体内进行疼痛行为测试 (正式的脚测试,热板测试).
主要成果:
- DHEAS被确定为一种内源调节器,可以减弱Gq合受体诱导的Kv7电流 (Kv7.1,Kv7.2,Kv7.4,Kv7.5) 的抑制,而不会影响基底通道动力学.
- DHEAS保护Kv7.2电流免受4,5-双酸 (PIP2) 耗尽的影响.
- 在Kv7.2 (H558C) 中的一种特定突变取消了DHEAS效应,支持了直接相互作用.
- 在体内,DHEAS的使用在甲胺试验中减少了晚期炎症性疼痛反应,这种效应被Kv7抑制剂阻断.
- DHEAS在甲胺试验中没有影响急性疼痛反应,在热板试验中也没有影响热痛.
结论:
- DHEAS通过稳定PIP2和Kv7通道之间的相互作用来减弱M电流抑制.
- 在炎症性疼痛模型中,DHEAS表现出止痛作用,可能是通过Kv7通道调制.
- DHEAS代表了一种新的治疗点,用于涉及高神经元刺激性和炎症性疼痛的疾病.
相关概念视频
01:25Analgesia and Pain Management
654
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
654
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341
01:24Non-gated Ion Channels
6.9K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.9K